Form 4 filed by Hansen Gwenn
Hansen Gwenn filed this Form 4 on NRIX (Nurix Therapeutics, Inc.) with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-15 21:00:27 UTC.
- Accession
- 0001817160-26-000021
- Filer
- CIK 1817160
- Filed
- 2026-10-15
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: NRIX · Nurix Therapeutics, Inc. (CIK 1549595)
- Hansen Gwenn officer (Chief Scientific Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-15 | M exercised | +1,452 | $1.86 | 118,679 | D |
| Common Stock | 2026-10-15 | S sold | -1,452 | $25 | 117,227 | D |
| Employee Stock Option (right to buy) derivative | 2026-10-15 | M exercised | -1,452 | $0 | 59,406 | D |